Connection

Chenthamarakshan Vasu to Dendritic Cells

This is a "connection" page, showing publications Chenthamarakshan Vasu has written about Dendritic Cells.
Connection Strength

2.008
  1. Engineered Dendritic Cell-Directed Concurrent Activation of Multiple T cell Inhibitory Pathways Induces Robust Immune Tolerance. Sci Rep. 2019 08 19; 9(1):12065.
    View in: PubMed
    Score: 0.592
  2. Dendritic cell-directed CTLA-4 engagement during pancreatic beta cell antigen presentation delays type 1 diabetes. J Immunol. 2010 Jun 15; 184(12):6695-708.
    View in: PubMed
    Score: 0.312
  3. Modulation of dendritic cell function and cytokine production to prevent thyroid autoimmunity. Autoimmunity. 2003 Sep-Nov; 36(6-7):389-96.
    View in: PubMed
    Score: 0.196
  4. Selective induction of dendritic cells using granulocyte macrophage-colony stimulating factor, but not fms-like tyrosine kinase receptor 3-ligand, activates thyroglobulin-specific CD4+/CD25+ T cells and suppresses experimental autoimmune thyroiditis. J Immunol. 2003 Jun 01; 170(11):5511-22.
    View in: PubMed
    Score: 0.192
  5. Activation of T cell checkpoint pathways during ?-cell antigen presentation by engineered dendritic cells promotes protection from type 1 diabetes. Immunology. 2022 07; 166(3):341-356.
    View in: PubMed
    Score: 0.178
  6. Fungal ?-glucan, a Dectin-1 ligand, promotes protection from type 1 diabetes by inducing regulatory innate immune response. J Immunol. 2014 Oct 01; 193(7):3308-21.
    View in: PubMed
    Score: 0.105
  7. OX40L/Jagged1 cosignaling by GM-CSF-induced bone marrow-derived dendritic cells is required for the expansion of functional regulatory T cells. J Immunol. 2013 Jun 01; 190(11):5516-25.
    View in: PubMed
    Score: 0.096
  8. GM-CSF-induced CD11c+CD8a--dendritic cells facilitate Foxp3+ and IL-10+ regulatory T cell expansion resulting in suppression of autoimmune thyroiditis. Int Immunol. 2009 Mar; 21(3):269-82.
    View in: PubMed
    Score: 0.071
  9. Modulation of dendritic cells using granulocyte-macrophage colony-stimulating factor (GM-CSF) delays type 1 diabetes by enhancing CD4+CD25+ regulatory T cell function. Clin Immunol. 2009 May; 131(2):260-70.
    View in: PubMed
    Score: 0.071
  10. Preferential costimulation by CD80 results in IL-10-dependent TGF-beta1(+) -adaptive regulatory T cell generation. J Immunol. 2008 May 15; 180(10):6566-76.
    View in: PubMed
    Score: 0.068
  11. Enhanced engagement of CTLA-4 induces antigen-specific CD4+CD25+Foxp3+ and CD4+CD25- TGF-beta 1+ adaptive regulatory T cells. J Immunol. 2007 Oct 15; 179(8):5191-203.
    View in: PubMed
    Score: 0.065
  12. IL-1? promotes TGF-?1 and IL-2 dependent Foxp3 expression in regulatory T cells. PLoS One. 2011; 6(7):e21949.
    View in: PubMed
    Score: 0.021
  13. Suppression of experimental autoimmune myasthenia gravis by granulocyte-macrophage colony-stimulating factor is associated with an expansion of FoxP3+ regulatory T cells. J Immunol. 2006 Oct 15; 177(8):5296-306.
    View in: PubMed
    Score: 0.015
  14. IL-10-producing CD4+CD25+ regulatory T cells play a critical role in granulocyte-macrophage colony-stimulating factor-induced suppression of experimental autoimmune thyroiditis. J Immunol. 2005 Jun 01; 174(11):7006-13.
    View in: PubMed
    Score: 0.014
  15. Absence of IL-4, and not suppression of the Th2 response, prevents development of experimental autoimmune Graves' disease. J Immunol. 2003 Feb 15; 170(4):2195-204.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.